These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. Ma WK, Poon DM, Chan CK, Chan TW, Cheung FY, Ho LY, Lee EK, Leung AK, Leung SY, So HS, Tam PC, Kwong PW. BJU Int; 2019 Aug; 124(2):221-241. PubMed ID: 30653801 [Abstract] [Full Text] [Related]
9. Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong. Wong MMC, Chung AKK, Yeung TMH, Wong DTW, Lee CK, Lai E, Chan GFY, Mak GKL, Wong JOY, Ng RMK, Tam KL, Mak KY. Intern Med J; 2020 Sep; 50 Suppl 3():6-14. PubMed ID: 32985093 [Abstract] [Full Text] [Related]
10. Consensus statements on adherence issues in schizophrenia for Hong Kong. Mak KY, Lo WT, Yeung WS, Wong M, Chung WS, Chui E, Tam KL, Hui LK, Mui J, Chan OW, Wong KL. Asian J Psychiatr; 2014 Dec; 12():163-9. PubMed ID: 25440570 [Abstract] [Full Text] [Related]
14. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A. Eur Urol; 2020 Apr; 77(4):508-547. PubMed ID: 32001144 [Abstract] [Full Text] [Related]
16. Management of overactive bladder: consensus statements from the Hong Kong Urological Association and the Hong Kong Geriatrics Society. Wong WKK, Kan RWM, Lam PS, Cheung PMH, Cheng EYL, Pun TCT, Tang MWS, Leung CLH, Woo SWS, Lo TK, Chu PSK, Chan TNH, Chiu PKF. Hong Kong Med J; 2024 Aug; 30(4):310-319. PubMed ID: 39138142 [Abstract] [Full Text] [Related]
17. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement. Merriel SWD, Hetherington L, Seggie A, Castle JT, Cross W, Roobol MJ, Gnanapragasam V, Moore CM, Prostate Cancer UK Expert Reference Group on Active Surveillance. BJU Int; 2019 Jul; 124(1):47-54. PubMed ID: 30742733 [Abstract] [Full Text] [Related]
18. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong. Fong JK, Chan EL, Leung H, Chan I, Chang RS, Fong GC, Fung EL, Lui CH, Fung BB, Poon TL, Siu D, Wong HT, Yeung E, Yung AW, Zhu CX, Subcommittee on the Consensus Statement of The Hong Kong Epilepsy Society. Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017 [Abstract] [Full Text] [Related]
19. Consensus statements on the clinical understanding and use of bupropion in Hong Kong. Lee WK, Au Yeung KL, Lam HB, Wong CK, Wong TC, Fu CK, Sham SK, Au MK, Lam TC, Ki-Yan Mak D. CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):20-24. PubMed ID: 33555615 [Abstract] [Full Text] [Related]
20. [Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen : Critical review of the recommendations on diagnosis and therapy of metastatic prostate cancer by a German expert panel]. Thomas C, Bögemann M, König F, Machtens S, Schostak M, Steuber T, Heidenreich A. Urologe A; 2016 Jun; 55(6):772-82. PubMed ID: 26820660 [Abstract] [Full Text] [Related] Page: [Next] [New Search]